Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
69M
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
68.2M
-
Shares change
-
-2.48M
-
Total reported value, excl. options
-
$668M
-
Value change
-
-$3.15M
-
Put/Call ratio
-
0.03
-
Number of buys
-
59
-
Number of sells
-
-50
-
Price
-
$9.79
Significant Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q3 2025
142 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock as of Q3 2025.
Olema Pharmaceuticals, Inc. - Common Stock (OLMA) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.2M shares
of 69M outstanding shares and own 98.95% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (6.84M shares), Paradigm Biocapital Advisors LP (6.79M shares), BVF INC/IL (5.3M shares), BlackRock, Inc. (4.73M shares), JANUS HENDERSON GROUP PLC (3.59M shares), Deep Track Capital, LP (3.47M shares), Logos Global Management LP (3.21M shares), VANGUARD GROUP INC (3.2M shares), FRANKLIN RESOURCES INC (3.01M shares), and Woodline Partners LP (2.22M shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.